{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:27:20Z","timestamp":1769765240385,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["bord personal disord emot dysregul"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Using traditional pharmacotherapy to treat Borderline Personality Disorder (BPD) such as mood stabilizers and second-generation antipsychotics has a lack of supporting evidence. Buprenorphine\/Naloxone (BUP\/N), a combination medication consisting of a partial opioid agonist, and a full opioid antagonist, is an effective treatment for opioid use disorder. It has also been found effective for treatment-resistant mood disorders. Previous studies suggest a relationship between BPD and endogenous opioids, therefore our case report investigates the effect of BUP\/N on a patient diagnosed with BPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 26-year-old female diagnosed with BPD, having recurrent visits to the emergency department (ED) for self-harm\/suicidality was treated with BUP\/N. Usage of crisis services, ED visits, and hospital admissions were tracked from 15 months prior to BUP\/N to 15 months after using BUP\/N. Since starting BUP\/N, the length and frequency of mental health-related hospital admissions decreased drastically, as did the number of times that she reached out to community crisis services. Since the dosing adjustment to 6\u00a0mg in Oct 2020, there have been no calls to the community crisis lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We suggest pharmacological treatment targeting BPD as a disorder of distress tolerance and self-soothing mediated by the opioid system is an effective individual healing attempt. An important note is that this patient did not use opioids prior to BUP\/N and had never been diagnosed with an opioid use disorder. However, she exhausted multiple other pharmacologic therapies and was open to trying whatever was available to improve her quality of life.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40479-022-00181-1","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:02:56Z","timestamp":1647302576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The use of buprenorphine\/naloxone to treat borderline personality disorder: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Brenna","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn M.","family":"Inch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenna A.","family":"Kaschor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"1","key":"181_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/YCO.0000000000000373","volume":"31","author":"V Starcevic","year":"2018","unstructured":"Starcevic V, Janca A. Pharmacotherapy of borderline personality disorder. Curr Opin Psychiatry. 2018;31(1):69\u201373.","journal-title":"Curr Opin Psychiatry"},{"issue":"8","key":"181_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1176\/appi.ajp.2010.09091348","volume":"167","author":"A Prossin","year":"2010","unstructured":"Prossin A, Love T, Koeppe R, Zubieta J, Silk K. Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry. 2010;167(8):925\u201333.","journal-title":"Am J Psychiatry"},{"key":"181_CR3","volume-title":"The archaeology of mind","author":"J Panksepp","year":"2012","unstructured":"Panksepp J, Biven L. The archaeology of mind. New York: W.W. Norton; 2012."},{"issue":"4","key":"181_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0193-953X(18)30082-0","volume":"17","author":"BA van der Kolk","year":"1994","unstructured":"van der Kolk BA, Hostetler A, Herron N, Fisler RE. Trauma and the development of borderline personality disorder. Psychiatr Clin North Am. 1994;17(4):715\u201330.","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"181_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1360-0443.2008.02244.x","volume":"103","author":"C Welsh","year":"2008","unstructured":"Welsh C, Sherman S, Tobin K. A case of heroin overdose reversed by sublingually administered buprenorphine\/naloxone (Suboxone\u00ae). Addiction. 2008;103(7):1226\u20138.","journal-title":"Addiction"},{"issue":"2","key":"181_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biopsych.2014.11.024","volume":"79","author":"NJ Kolla","year":"2016","unstructured":"Kolla NJ, Chiuccariello L, Wilson AA, Houle S, Links P, Bagby RM, et al. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition. Biol Psychiatry. 2016;79(2):117\u201326.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"181_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40473-017-0102-0","volume":"4","author":"NJ Kolla","year":"2017","unstructured":"Kolla NJ, Vinette SA. Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder. Curr Behav Neurosci Rep. 2017;4(1):41\u20138.","journal-title":"Curr Behav Neurosci Rep"},{"key":"181_CR8","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.); 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"5","key":"181_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1037\/0012-1649.28.5.759","volume":"28","author":"I Bretherton","year":"1992","unstructured":"Bretherton I. The origins of attachment theory: John Bowlby and Mary Ainsworth. Dev Psychol. 1992;28(5):759\u201375.","journal-title":"Dev Psychol"}],"container-title":["Borderline Personality Disorder and Emotion Dysregulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40479-022-00181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40479-022-00181-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40479-022-00181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:05:41Z","timestamp":1647302741000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpded.biomedcentral.com\/articles\/10.1186\/s40479-022-00181-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1186\/s40479-022-00181-1","relation":{},"ISSN":["2051-6673"],"issn-type":[{"value":"2051-6673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable - the case report did not require formal research ethics board approval as per our institution\u2019s guidelines. The patient provided informed written consent and the information was collected retrospectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0and consent to participate"}},{"value":"All authors approved the manuscript and agree with its submission to Borderline Personality Disorder and Emotion Dysregulation. This manuscript describes original work and is not under consideration by any other journal. Informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}